Diana Hausman, M.D.

Diana Hausman, M.D.

Former Chief Medical OfficeratZentalis Pharmaceuticals· In proxies 2023–2024

Pay in FY2024Zentalis Pharmaceuticals stock -80.0% the same year

Diana Hausman, M.D. was paid $7.1M in FY2024 (Dec). Zentalis Pharmaceuticals stock fell 80.0% that year.

Pay$100 in the stock at the end of FY23 → $20
Pay is from the Summary Compensation Table of each Zentalis Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Zentalis PharmaceuticalsPublic company · 3 yr
    • Former Chief Medical Officer2023 – Present · 3 yrStock in role -89%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?